Drug
retifanlimab-dlwr
Marketed as ZYNYZ.
Generic name
retifanlimab-dlwr
Brand names
ZYNYZ
First FDA approval
2023-03-22
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761334 | ZYNYZ | 2023-03-22 | INCYTE CORP |
Manufacturers
INCYTE CORP
Frequently asked questions
When was retifanlimab-dlwr FDA approved?
Earliest FDA approval on record: 2023-03-22.
What brand names are sold as retifanlimab-dlwr?
ZYNYZ.
Sources
Appeal a retifanlimab-dlwr denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com